Related Experiment Videos
Arylpiperazines with serotonin-3 antagonist activity: a comparative molecular field analysis
A Morreale1, E Gálvez-Ruano, I Iriepa-Canalda
1Department of Chemistry, Indiana University-Purdue University at Indianapolis (IUPUI), 402 North Blackford Street, Indianapolis, Indiana 46202-3274, USA.
Journal of Medicinal Chemistry
|June 17, 1998
Summary
Comparative molecular field analysis (CoMFA) effectively models 5-HT3 receptor antagonists. Protonated arylpiperazines yielded better results, with novel structural modifications interpretable by the CoMFA model.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Pharmacology
Background:
- The 5-HT3 receptor is a key target for drugs treating conditions like nausea and irritable bowel syndrome.
- Understanding the structure-activity relationships of 5-HT3 receptor antagonists is crucial for drug design.
Purpose of the Study:
- To apply Comparative Molecular Field Analysis (CoMFA) to a series of arylpiperazine 5-HT3 receptor antagonists.
- To investigate the influence of molecular conformation, charge calculation methods, and protonation states on CoMFA model performance.
Main Methods:
- CoMFA was performed on three separate and a combined set of arylpiperazine antagonists.
- d-Tubocurarine was used as a template for molecular alignment.
- Neutral and protonated forms were analyzed using Gasteiger-Hückel, AM1, and solvated AM1 charges.
Main Results:
- Protonated structures provided superior statistical results compared to neutral forms.
- Charge calculation methods had minimal impact on the overall results.
- The CoMFA model achieved an average cross-validated r2 (r2cv) of 0.70 on the combined set of 47 compounds.
- The model accurately predicted pKi values for external test compounds with a mean agreement of 0.7 log units.
Conclusions:
- CoMFA is a viable method for modeling 5-HT3 receptor antagonists.
- Protonation state significantly influences the predictive power of CoMFA models for these compounds.
- The developed CoMFA model can interpret novel structural modifications and guide future drug design efforts.